US$ 27.67
glp-1 agonists drugs How medications are transforming diabetes and weight loss treatment GLP-1 Agonists: A Comprehensive Overview
Description
In the Phase 2 T2D trial, exploratory analyses showed significant reductions in liver fat content with retatrutide

That is not a good assumption

Biomedicines (2022) 10(7):1688

24 In this review, we discuss the benefits and challenges associated with the small-molecule GLP-1 RA drugs from pre-clinical and clinical studies

A review of dipeptidyl peptidase-4 inhibitors

The safety profile of the DPP-4 inhibitors is also favorable and last not least, there are fixed dose combinations with metformin and DPP-4 inhibitors available
